未知股票 VXRT 深 沪
已收盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 2.41亿
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 0.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vaxart Earnings Call: Big Deals, Bigger Expectations
Vaxart (($VXRT)) has held its Q4 earnings call. Read on for the main highlights...
03-18 08:14
2026年值得关注的5美元以下高潜力股票
TradingKey - 尽管目前投资者似乎呈现出远离投机性低价股的趋势，但仍有许多投资者更倾向于承担风险，以博取持有此类股票的潜在收益。
03-16 08:53
High-Potential Stocks Under $5 to Watch in 2026
TradingKey - While there seems to be a trend of investors moving away from speculative penny stocks, there are still many investors who are more inclined to take the risk and see the possible rewards of holding these types of stocks.
03-16 08:51
Vaxart Q4 EPS $0.24 Beats $(0.05) Estimate, Sales $104.239M Beat $69.700M Estimate
Vaxart (OTC:VXRT) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $(0.05) by 580 percent. This is a 700 percent increase over losses of $(0.04) per share from the same period
03-13 04:54
Major earnings expected after the bell on Thursday include:
Major earnings expected after the bell on Thursday include: Adobe (ADBE) Wheaton Precious Metals Corp. (WPM) SentinelOne (S) Inovio Pharmaceuticals (INO) Ulta Beauty (ULTA) Other Earnings slated for r...
03-12 22:00
Vaxart to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Vaxart to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference Vaxart, Inc. will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference, held virtually February 25–26, 2026, with its presentation scheduled for Wednesday, February 25 at 4:00 p.m. ET. Registration
02-18 21:09
Vaxart Publishes Data From Phase 1 Study Of Single-Dose, Oral Bivalent Vaccine Candidate In Post-Partum, Breastfeeding Women
Vaxart, Inc. (OTCQX: VXRT) ("Vaxart" or the "Company"), a clinical-stage biotechnology company developing a range of oral vaccines based on its proprietary delivery platform, today announced the publication in npj
01-15 21:07
Vaxart to Relocate Headquarters Amid Lease Termination
Vaxart ( ($VXRT) ) has shared an announcement. On December 18, 2025, Vaxart, In...
2025-12-29 21:34
Vaxart Inc. Director W. Mark Watson Acquires Common Shares
W. Mark Watson, Director at Vaxart Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created b...
2025-12-06 06:47
Vaxart Secures $30 Million From Dynavax for Oral COVID-19 Vaccine License
Vaxart Inc. has announced an exclusive license agreement with Dynavax Technologies for its novel oral COVID-19 vaccine program. Under the terms of the agreement, Dynavax will pay Vaxart a $25 million ...
2025-11-06 05:00
